| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.033 | 0.8 |